ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Knowlden, Janice Mary, McClelland, Richard Andrew, Jordan, Nicola Jane, Wakeling, A. E. and Nicholson, Robert Ian 2002. ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]. European Journal of Cancer 38 (S7) , S59. 10.1016/S0959-8049(02)80835-8

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Additional Information:	Abstract for Poster session Signal transduction modulators
Publisher:	Elsevier
ISSN:	0014-2964
Last Modified:	18 Oct 2022 14:20
URI:	https://orca.cardiff.ac.uk/id/eprint/17182

Citation Data

Actions (repository staff only)

Edit Item